eli lilly clinical trials tirzepatide gets a big win in obesity-related heart failure Lilly’s New Tirzepatide Add On!

Some podiatrists are calling the adverse reaction Ozempic feet. Thats because when people lose a lot of weight quickly, their feet also lose fat

Our analysis indicates that between 20 and 30 percent of annual patients stop using the drugs, particularly those focused on weight loss, and these patients regain about two-thirds of the weight they lost

If I were designing a stack specifically for someone whose primary goal is losing 30 to 50 pounds while maintaining their training capacity, this would be my first recommendation

Under general anesthesia or deep sedation, that same slowing becomes a different kind of problem